Linked In Amanda Combs, recall consultant - Sedgwick
Latest Coronavirus updates from Sedgwick Back to business solutions

Amanda Combs

recall consultant
Amanda Combs

Amanda has helped scope, plan and execute more than 600 national and international product recalls across a diverse set of industries, including pharmaceutical, medical, food, automotive and consumer product. In her 15+ years with the company, Amanda has worked on all aspects of product recalls and remediations, from the implementation of prevention strategies to the execution of global programs.

Media
View
Blog
April 30, 2021
Amanda Combs
recall consultant
Revelations of another carcinogen in hand sanitizers puts more pressure on manufacturers

More than a year after the start of the COVID-19 pandemic, hand sanitizers are making headlines again. This time there are new revelations about the existence of high levels of the carcinogen benzene in sanitizers widely available to the public. An a…

April 30, 2021 by Amanda Combs, recall consultant
Blog
April 05, 2021
Amanda Combs
recall consultant
Stricter rules loom over dietary supplement industry

As dietary supplements rise in popularity, consumer advocates, regulators and lawmakers have become increasingly concerned that the current regulatory system is inadequate to ensure the products on the market are safe. Millions of Americans rely on d…

April 05, 2021 by Amanda Combs, recall consultant
Blog
December 01, 2020
Amanda Combs
recall consultant
Here’s what you need to know about fraudulent claims and phony COVID-19 products

From teas and essential oils to drugs, faulty masks, and other medical products, COVID-19 has brought a wave of deceptive marketing and fraud.Early on in the pandemic, the U.S. Food and Drug Administration (FDA) and the Federal Trade Commission (FTC)…

December 01, 2020 by Amanda Combs, recall consultant
Blog
September 23, 2020
Amanda Combs
recall consultant
What the FDA’s Nitrosamine impurity guidance means for drug manufacturers

It’s been over two years since carcinogenic nitrosamines were discovered in some widely used drugs. The discovery occurred in 2018 when the contaminant was found in active pharmaceutical ingredients in Valsartan, a blood pressure medication. Since th…

September 23, 2020 by Amanda Combs, recall consultant
Blog
August 07, 2020
Amanda Combs
recall consultant
Your “excellent” recall crisis plan may damage your reputation, new study reveals

In their quest for excellence, many companies try to amaze their customers with superior products and even better service. More than a few have extended that philosophy to their crisis planning, offering free products, cash, generous coupons and othe…

August 07, 2020 by Amanda Combs, recall consultant
Blog
March 27, 2020
Amanda Combs
recall consultant
Cosmetic safety legislation threatens to spur more recalls

Cosmetic companies have been a target of consumer activists for years. Organizations like Environmental Working Group and Campaign for Safe Cosmetics have run campaigns that resulted in companies reformulating products or defending themselves publicl…

March 27, 2020 by Amanda Combs, recall consultant
Blog
March 18, 2020
Amanda Combs
recall consultant
Future cost of COVID-19 on pharma manufacturers

As the number of COVID-19 cases continues to increase worldwide, numerous questions and a tremendous amount of misinformation cloud the issue. Many remain confused about how the virus is transmitted, how dangerous it is, and what treatments for it ma…

March 18, 2020 by Amanda Combs, recall consultant
Blog
October 30, 2019
Amanda Combs
recall consultant
Infant bedding in Consumer Reports' crosshairs, CPSC scrutiny to follow

For parents, especially first-time moms and dads, learning the do’s and don’ts of raising a child is like drinking from a firehose. But parents aren’t the only ones facing information overload when it comes to all the products on the market and th…

October 30, 2019 by Amanda Combs, recall consultant
Blog
October 09, 2019
Amanda Combs
recall consultant
FDA’s recall planning guidance offers little new insight

FDA started issuing draft industry guidance related to Hazard Analysis and Risk-Based Preventive Controls for Human Food (PCHF) in January 2018, but the 16 chapters are still a work in progress. Most recently, the FDA alerted the industry in the fede…

October 09, 2019 by Amanda Combs, recall consultant
Blog
August 28, 2019
Amanda Combs
recall consultant
Pressure rises at CPSC over home elevators

The Consumer Product Safety Commission has been in the hot seat lately, criticized for its handling of recent children’s and infant product recalls. The latest chapter in the “failure to act” saga features in-home elevators that are putting children …

August 28, 2019 by Amanda Combs, recall consultant
End of results.
Back to top